It is vital that the first authorised at-home, non-prescription Covid-19 antigen test be used in the right way.
A new UK plan to use antigen tests for wide-scale screening for Covid-19 may not be the easy win the government is seeking.
Though orthopaedics companies have begun to recover from the second quarter’s horrors, it is clear that the third quarter belongs to the diagnostics specialists.
Beset with problems from the off, the Lotus Edge aortic valve has finally been discontinued.
Despite the FDA’s warning that antigen assays may only be used in patients with symptoms, one such test shows potential in the screening setting.
The newest player in corporate financing, Intuitive, intends to deploy its fund with surgical precision.
Antigen tests for Covid-19 can be useful if used in the right settings, but those settings are expensive.
Slower labs are to be paid less for Covid-19 tests, but will the move actually speed things up?
The new regulatory scheme poses problems – but also opportunities, in the shape of possible alignment with the US.